We are live on
!
Find out more
OAG
Orbis Allan Gray Portfolio holdings
AUM
$29.1B
1-Year Est. Return
60.8%
This Fund
S&P 500
This Quarter
Est. Return
+13.86%
1 Year Est. Return
+60.8%
3 Year Est. Return
+154.65%
5 Year Est. Return
+203.47%
10 Year Est. Return
+909.03%
AUM
$14.3B
AUM Growth
+$786M
(+5.8%)
Cap. Flow
-$887M
Cap. Flow
% of AUM
-6.19%
Top 10 Holdings %
Top 10 Hldgs %
67.76%
Holding
67
New
7
Increased
20
Reduced
21
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$314M |
| 2 |
Fomento Económico Mexicano
FMX
|
+$174M |
| 3 |
British American Tobacco
BTI
|
+$135M |
| 4 |
Altria Group
MO
|
+$122M |
| 5 |
APA Corp
APA
|
+$63.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$714M |
| 2 |
NetEase
NTES
|
+$302M |
| 3 |
XPO
XPO
|
+$161M |
| 4 |
Dollar General
DG
|
+$107M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$93.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 32.72% |
| 2 | Healthcare | 21.11% |
| 3 | Industrials | 13.77% |
| 4 | Consumer Staples | 7.32% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NetEase
NTES
$78.6B
| $2.56B | 17.87% |
41,743,700
-5,158,705
| -11% | -$302M |
|
|
2
XPO
XPO
$22.4B
| $1.49B | 10.42% |
54,171,490
-5,851,565
| -10% | -$161M |
|
3
AbbVie
ABBV
$456B
| $1.43B | 9.95% |
16,098,296
-1,126,356
| -7% | -$93.5M |
|
4
Autohome
ATHM
$2.6B
| $718M | 5.02% |
8,978,526
-738,603
| -8% | -$57.5M |
|
5
Elevance Health
ELV
$86.6B
| $694M | 4.85% |
2,297,796
+13,693
| +0.6% | +$3.77M |
|
6
Alphabet (Google) Class C
GOOG
$4.13T
| $691M | 4.82% |
10,336,140
-163,160
| -2% | -$10.5M |
|
7
Meta Platforms (Facebook)
META
$1.45T
| $675M | 4.72% |
3,290,920
-288,231
| -8% | -$55.8M |
|
8
UnitedHealth
UNH
$355B
| $549M | 3.83% |
1,867,227
+606
| +0% | +$159K |
|
|
9
British American Tobacco
BTI
$121B
| $458M | 3.2% |
10,794,470
+3,594,213
| +50% | +$135M |
|
10
Vale
VALE
$65.2B
| $441M | 3.08% |
33,377,499
| – | – |
|
|
11
APA Corp
APA
$14.8B
| $407M | 2.84% |
15,912,946
+2,792,036
| +21% | +$63.2M |
|
12
Howmet Aerospace
HWM
$107B
| $376M | 2.63% |
15,951,537
-11,269
| -0.1% | -$252K |
|
|
13
Bristol-Myers Squibb
BMY
$137B
| $352M | 2.46% |
+5,481,869
| New | +$314M |
|
14
S&P Global
SPGI
$128B
| $341M | 2.38% |
1,247,548
-270,504
| -18% | -$70.3M |
|
15
Itaú Unibanco
ITUB
$83B
| $307M | 2.14% |
46,124,518
-1,785,216
| -4% | -$11.2M |
|
16
TSMC
TSM
$2.22T
| $295M | 2.06% |
5,078,401
-174,150
| -3% | -$9.24M |
|
|
17
Dollar General
DG
$27.8B
| $265M | 1.85% |
1,696,656
-675,036
| -28% | -$107M |
|
18
SPDR Gold Trust
GLD
$154B
| $231M | 1.61% |
1,613,664
| – | – |
|
19
Sensata Technologies
ST
$6.18B
| $211M | 1.47% |
3,914,479
+311,656
| +9% | +$16M |
|
|
BERY
20
DELISTED
Berry Global Group, Inc.
BERY
| $191M | 1.33% |
4,384,169
-2,370,816
| -35% | -$93.9M |
|
|
21
Fomento Económico Mexicano
FMX
$41B
| $184M | 1.29% |
1,949,891
+1,895,833
| +3,507% | +$174M |
|
22
Alcoa
AA
$13.5B
| $171M | 1.19% |
7,942,484
+1,636,991
| +26% | +$33.9M |
|
23
Golar LNG
GLNG
$5.26B
| $158M | 1.1% |
11,079,903
+293,724
| +3% | +$3.98M |
|
|
RDS.B
24
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $151M | 1.05% |
2,511,203
+2,245
| +0.1% | +$132K |
|
25
Wells Fargo
WFC
$257B
| $142M | 0.99% |
2,636,100
-739,507
| -22% | -$38.7M |
|
Similar funds
TCIIS
GMC
FAM
Orbis Allan Gray's Q4 2019 Portfolio in Review
As of Q4 2019, Orbis Allan Gray held 67 positions worth $14.3B, up 5.8% from $13.5B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Orbis Allan Gray withdrew a net $887M in Q4 2019, closing 4 positions and reducing 21 holdings. Its most notable exit was Celgene Corp, an estimated $714M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Orbis Allan Gray opened a new position in Bristol-Myers Squibb worth $352M.
- Orbis Allan Gray's largest Q4 2019 buy was Bristol-Myers Squibb: 5,481,869 shares worth $352M.
- Orbis Allan Gray added most to Fomento Económico Mexicano in Q4 2019, an estimated $174M increase.
- Orbis Allan Gray's biggest Q4 2019 reduction was NetEase, cutting an estimated $302M.
- Orbis Allan Gray fully exited Celgene Corp in Q4 2019, selling an estimated $714M.
- Orbis Allan Gray's ten largest holdings make up 68% of its $14.3B portfolio in Q4 2019.
- Orbis Allan Gray opened 7 new positions and closed 4 in Q4 2019.
- Orbis Allan Gray's portfolio value rose 5.8% quarter-over-quarter to $14.3B.
Based on Orbis Allan Gray's 13F filing for Q4 2019, filed 14 Feb 2020.